| Size & multiples | |||
| Market Cap | $1.15T | Enterprise Value | $1.18T |
| P/E (TTM) | 53.19× | PEG (trailing) | 1.08× |
| P/S | 15.91× | P/FCF | — |
| EV/EBITDA | 41.33× | EV/EBIT | 44.50× |
| EV/Sales | 16.40× | EV/FCF | — |
| FCF Yield | — | Buyback Yield | 0.46% |
| Owner Earnings Yield | — | Shareholder Yield | 0.94% |
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 0.50 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 6.49% |
| After-tax Cost of Debt | 1.69% | Synthetic credit rating | AAA |
| Cost of Debt · embedded (pre-tax) | 2.11% | Cost of Debt · marginal (synthetic) | 4.40% |
| WACC | 6.31% | ROIC | 40.20% |
| EVA Spread (ROIC−WACC) | 33.88% | EVA | $20.93B |
Synthetic rating = ICR-based credit-quality read (Damodaran), not an agency rating.
Flows TTM (last 4 quarters); latest annual for: EPS (Diluted) · EPS TTM $22.95 · revenue TTM $72.25B · FCF TTM —
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Rich vs Health Care on P/E
P/E 83rd percentile in the Health Care pool — placement read per multiple; the API emits no single blended figure, so none is shown.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| P/E | 53.2x | 24.4x | 13.0x–39.3x | 83 ↑rich |
| Dividend Yield | 0.5% | 1.1% | 0.2%–2.4% | 32 ↓weak |
| Net Margin | 31.7% | -21.2% | -325.3%–7.2% | 95 ↑strong |
| ROE | 101.2% | -36.8% | -92.5%–4.5% | 99 ↑strong |
